U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 2 of 2 results

Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Iofratol, is a dimeric, hexaiodinated radiographic contrast agent that was being developed by Bracco as a potential X-ray contrast medium for angiography and myelography.
Status:
US Previously Marketed
First approved in 1978

Class (Stereo):
CHEMICAL (ABSOLUTE)


Metrizamide is a glucosamine derivative of metrazoic acid, used as a contrast medium for myelography. Metrizamide is no longer marketed in the US.